Cargando…

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammed, Altaf, Dashwood, Roderick H., Dickinson, Sally, Disis, Mary L., Jaffee, Elizabeth M., Johnson, Bryon D., Khleif, Samir N., Pollak, Michael N., Schlom, Jeffrey, Shoemaker, Robert H., Stanton, Sasha E., Wondrak, Georg T., You, Ming, Zhu, Hao, Miller, Mark Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Cancer Prevention 2021
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749317/ https://www.ncbi.nlm.nih.gov/pubmed/35047458 http://dx.doi.org/10.15430/JCP.2021.26.4.309

Ejemplares similares

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018)

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
por: Miller, Mark Steven, et al.
Publicado: (2021)

Phytochemicals as Immunomodulatory Agents in Melanoma
por: Tabolacci, Claudio, et al.
Publicado: (2023)

Immunomodulatory Agents for Multiple Myeloma
por: Minařík, Jiří, et al.
Publicado: (2022)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents
por: Kurtin, Sandra E., et al.
Publicado: (2013)

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

The role of adjuvant immunomodulatory agents for treatment of severe influenza
por: Hui, David S., et al.
Publicado: (2018)

Plant microRNAs as novel immunomodulatory agents
por: Cavalieri, Duccio, et al.
Publicado: (2016)

Bacterial flagellin—a potent immunomodulatory agent
por: Hajam, Irshad A, et al.
Publicado: (2017)

Fructans as Immunomodulatory and Antiviral Agents: The Case of Echinacea
por: Dobrange, Erin, et al.
Publicado: (2019)

COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology
por: Değirmenci, Mehmet Fatih Kağan, et al.
Publicado: (2021)

Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia
por: McManus, Dayna, et al.
Publicado: (2023)

Natural biomolecules and derivatives as anticancer immunomodulatory agents
por: Bernitsa, Stavroula, et al.
Publicado: (2023)

Clinical significance of tumor-infiltrating lymphocytes in breast cancer
por: Stanton, Sasha E., et al.
Publicado: (2016)

Development of oral immunomodulatory agents in the management of multiple sclerosis
por: Nicholas, Richard, et al.
Publicado: (2011)

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
por: Chanan-Khan, A A, et al.
Publicado: (2013)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013)

Targeting Immunomodulatory Agents to the Gut-Associated Lymphoid Tissue
por: Zgair, Atheer, et al.
Publicado: (2016)

Oncologic immunomodulatory agents in patients with cancer and COVID-19
por: Jee, Justin, et al.
Publicado: (2021)

The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents
por: Pantic, Jelena M., et al.
Publicado: (2017)

High-throughput approaches to discover novel immunomodulatory agents for cancer
por: McMillin, Douglas W., et al.
Publicado: (2012)

Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
por: Dashwood, Roderick H.
Publicado: (2021)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

Role of Anti-Cancer Peptides as Immunomodulatory Agents: Potential and Design Strategy
por: Tripathi, Amit Kumar, et al.
Publicado: (2022)

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer
por: Stanton, Sasha E, et al.
Publicado: (2013)

Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents
por: Kotb, Anas Ramadan, et al.
Publicado: (2022)

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy
por: Fazio, Carolina, et al.
Publicado: (2018)

Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer
por: Snell, Jeremy A., et al.
Publicado: (2022)

Immunomodulatory effects of tick saliva on dermal cells exposed to Borrelia burgdorferi, the agent of Lyme disease
por: Scholl, Dorothy C., et al.
Publicado: (2016)

Multiplexed Nanoplasmonic Temporal Profiling of T-Cell Response under Immunomodulatory Agent Exposure
por: Oh, Bo-Ram, et al.
Publicado: (2016)

Innate immune memory: implications for development of pediatric immunomodulatory agents and adjuvanted vaccines
por: Levy, Ofer, et al.
Publicado: (2013)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
por: Bach-Griera, Marc, et al.
Publicado: (2020)

Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
por: Mamber, Stephen W., et al.
Publicado: (2020)

Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection
por: Bahari, Zahra, et al.
Publicado: (2021)

PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients
por: Tarantelli, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6gl8563sc9f5j2sjfddtm7dgd